The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Ipsen; Janssen-Ortho; Sanofi; Takeda
Research Funding - Exelixis
Expert Testimony - Astellas Pharma; Janssen-Ortho; Sanofi
Final analysis of COMET-1: Cabozantinib (Cabo) versus prednisone (Pred) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) previously treated with docetaxel (D) and abiraterone (A) and/or enzalutamide (E).
 
Matthew Raymond Smith
Consulting or Advisory Role - Exelixis
Research Funding - Exelixis
 
Johann Sebastian De Bono
Research Funding - Exelixis
 
Cora N. Sternberg
Honoraria - Astellas Pharma; Janssen-Ortho; Medivation
Research Funding - Exelixis
 
Sylvestre Le Moulec
Research Funding - Exelixis
 
Stephane Oudard
Honoraria - Astellas Pharma; Janssen-Ortho; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Ortho; Pfizer; Roche; Sanofi
Research Funding - Exelixis
 
Ugo De Giorgi
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Janssen-Cilag; Novartis; Pfizer
Research Funding - Exelixis
 
Michael Krainer
Research Funding - Exelixis
 
Andre M. Bergman
Research Funding - Exelixis
 
Wolfgang Hoelzer
Research Funding - Exelixis
 
Ronald De Wit
Honoraria - Astellas Pharma; Exelixis; Janssen-Ortho; Millennium/Prometrika; Sanofi
Research Funding - Astellas Pharma; Exelixis; Janssen-Ortho; Millennium/Prometrika; Sanofi
 
Martin Boegemann
Research Funding - Exelixis
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Giorgio Cruciani
Research Funding - Exelixis
 
Antoine Thiery- Vuillemin
No Relationships to Disclose
 
Susan Feyerabend
Research Funding - Exelixis
 
Kurt Miller
Honoraria - Astellas Pharma; Bayer; Janssen-Ortho
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Research Funding - Exelixis
 
David Albert Ramies
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Colin Hessel
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Aaron Weitzman
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Karim Fizazi
Honoraria - Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Exelixis; Janssen; Sanofi
Research Funding - Exelixis